Immune biomarkers of anti-EGFR monoclonal antibody therapy

The tumor antigen (TA)-targeted monoclonal antibodies (mAb) cetuximab and panitumumab target the human epidermal growth factor receptor and have been integrated into treatment regimens for advanced squamous cell carcinoma of the head and neck (SCCHN). The therapeutic efficacy of these mAbs has been...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Oncol
Autors principals: Trivedi, S., Concha-Benavente, F., Srivastava, R. M., Jie, H. B., Gibson, S. P., Schmitt, N. C., Ferris, R. L.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Reviews
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4269339/
https://ncbi.nlm.nih.gov/pubmed/24997207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdu156
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars